These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2250203)

  • 1. Validation and environmental monitoring of aseptic processing. Committee on Microbial Purity.
    J Parenter Sci Technol; 1990; 44(5):272-7. PubMed ID: 2250203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Validation and environmental control of preparation operations. Fifth communication of the Comite des Laboratoires et Services Officiels de Controle des Medicaments et de la Section des Pharmaciens de l'Industrie'-F.I.P, May 1990].
    Pharm Acta Helv; 1990; 65(12):327-33. PubMed ID: 2103634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of environmental monitoring methods and levels.
    Noble NH
    J Parenter Sci Technol; 1993; 47(1):26-8. PubMed ID: 8445496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technical report: bioburden recovery validation. PDA Bioburden Recovery Validation Task Force. Parenteral Drug Association.
    J Parenter Sci Technol; 1990; 44(6):324-31. PubMed ID: 2277321
    [No Abstract]   [Full Text] [Related]  

  • 5. The index of microbial air contamination.
    Pasquarella C; Pitzurra O; Savino A
    J Hosp Infect; 2000 Dec; 46(4):241-56. PubMed ID: 11170755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous Microbiological Environmental Monitoring for Process Understanding and Reduced Interventions in Aseptic Manufacturing.
    Weber J; Hauschild J; Ijzerman-Boon P; Forng RY; Horsch J; Yan L; Prasad A; Henry RB; Claassen M; Villari P; Shereefa S; Wyatt J; Bolden JS; Pycke JT; Dassu D
    PDA J Pharm Sci Technol; 2019; 73(2):121-134. PubMed ID: 30361285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating aseptic technique of pharmacy personnel.
    Brier KL
    Am J Hosp Pharm; 1983 Mar; 40(3):400-3. PubMed ID: 6342376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In line validation of sanitizing agents in aseptic processing areas.
    Chesky SR
    J Parenter Sci Technol; 1986; 40(4):169-74. PubMed ID: 3095529
    [No Abstract]   [Full Text] [Related]  

  • 9. Panel discussion: environmental sampling in an aseptic environment. I. Microbiological environmental monitoring.
    Raiman HL
    Bull Parenter Drug Assoc; 1974; 28(6):253-60. PubMed ID: 4616742
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug impurities: problems and regulations.
    Pifferi G; Mannucci A
    Boll Chim Farm; 1999 Nov; 138(10):500-7. PubMed ID: 10765465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current practices in the validation of aseptic processing--1992.
    Agalloco J; Akers J
    J Parenter Sci Technol; 1993; 47 Suppl 1():S1-21. PubMed ID: 8515352
    [No Abstract]   [Full Text] [Related]  

  • 12. [Environmental Monitoring in a Pharmaceutical Manufacturing Facility Using a Culture Independent Approach].
    Kawai M
    Yakugaku Zasshi; 2022; 142(1):33-37. PubMed ID: 34980749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medicinal plants as objects of hygienic monitoring].
    Listov SA
    Gig Sanit; 1989 Dec; (12):89-90. PubMed ID: 2628211
    [No Abstract]   [Full Text] [Related]  

  • 14. Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact.
    Lowder JN; Whelton P
    Cytotherapy; 2003; 5(5):377-90. PubMed ID: 14578100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biotest RCS air samplers in unidirectional flow.
    Ljungqvist B; Reinmüller B
    J Pharm Sci Technol; 1994; 48(1):41-4. PubMed ID: 8004418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation study on how to avoid microbial contamination during pharmaceutical production.
    Shintani H
    Biocontrol Sci; 2015; 20(1):1-10. PubMed ID: 25817807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial Identification in Pharmaceutical Compounding.
    Hyde T; Anstead J; Schade L; Zellner J
    Int J Pharm Compd; 2016; 20(1):13-8. PubMed ID: 27125052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation and control of non-standard sterilization processes. Committee on Microbial Purity. FIP (International Pharmaceutical Federation).
    J Parenter Sci Technol; 1993; 47(1):9-15. PubMed ID: 8445502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boundary and airlock design issues in aseptic facilities.
    Lorenz MR; Robinson JE
    J Parenter Sci Technol; 1991; 45(6):279-85. PubMed ID: 1802984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of the aseptic processing environment.
    Frieben WR
    Am J Hosp Pharm; 1983 Nov; 40(11):1928-35. PubMed ID: 6650522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.